Dacoplice 30mg Tablet
By Dacoplice
Rx
30 Tablet in a Bottle

Composition
Dacomitinib(30mg)

Manufacturer - Pfizer Ltd
The Capital, 1802, 18th Floor , Plot No. C-70, 'G' Block , Bandra Kurla Complex, Bandra East , Mumbai – 400051.

Expires on or after
July, 2025

liver
Dacoplice 30mg Tablet can be used safely by patients with liver disease. There is no need to change the dose of Dacoplice 30mg Tablet for liver issues. However, if you have mild to moderate liver problems, it is important to tell your doctor before starting this medication. In cases of severe liver disease, the dosage of Dacoplice 30mg Tablet may need to be adjusted. It is crucial to follow your doctor's guidance regarding the use of this medicine if you have liver concerns.

kidney
Dacoplice 30mg Tablet is safe for use in patients with kidney disease. Inform your doctor if you have a history of kidney issues. No dose adjustment is needed for mild to moderate renal impairment.

alcohol
It is uncertain if alcohol interacts with Dacoplice 30mg Tablet. It is advisable to limit or avoid alcohol consumption. Consult your doctor for guidance.

driving
While taking Dacoplice 30mg Tablet, be cautious if you experience symptoms affecting concentration or reaction time. Avoid driving or operating machinery if you have blurred vision. Wait until your vision is clear before engaging in activities requiring sharp eyesight.

pregnancy
Dacoplice 30mg Tablet is considered unsafe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will evaluate the benefits versus risks before prescribing. It is advised to consult your doctor regarding its use in pregnancy.

breastfeeding
Dacoplice 30mg Tablet may not be safe to use during breastfeeding. Limited data suggests it could pass into breastmilk and harm the baby. Avoid breastfeeding while taking this medicine and for 17 days after the last dose.
Habit Forming | No |
Chemical Class | Quinazoline Derivative |
Therapeutic Class | - |
Action Class | - |
₹64050
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 11-Feb-2025